• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Abbott Labs Has the Formula for a Long Trade

ABT has made an upside breakout on the daily Point and Figure chart, and here's how investors can make their next move.
By BRUCE KAMICH
Jan 26, 2021 | 11:49 AM EST
Stocks quotes in this article: BA, ABT, FB, AAPL, TSLA

During Friday's "Mad Money" program, Jim Cramer gave viewers his game plan for this week. On Wednesday, we'll hear from the Federal Reserve, but Cramer wasn't expecting any changes. The earnings continue with Boeing  (BA)  and Abbott Labs (ABT)  two stocks that are still early in their rallies. After the close, it's a trifecta of tech darlings, Facebook (FB) , Apple (AAPL) and Tesla  (TSLA) .

 
Let's check out the charts of ABT first.  
 
In this daily bar chart of ABT, below, we can see that prices are very close to breaking above the highs of August and November. ABT is trading above the rising 50-day moving average line and the rising 200-day moving average line. The trading volume has remained steady the past five months instead of diminishing and that I consider a positive sign. The On-Balance-Volume (OBV) line has been moving up since early December and is close to making a new high. The Moving Average Convergence Divergence (MACD) oscillator gave us an outright buy signal earlier this month when it crossed above the zero-line. 
 
 
 
In this weekly bar chart of ABT, below, we see a constructive picture. Prices are in an uptrend above the rising 40-week moving average line. The weekly OBV line has been moving up since early December and is close to making a new high. The MACD oscillator showed weakness from November but has recently narrowed and is close to an upside crossover and buy signal. 
 
 
 
 
In this daily Point and Figure chart of ABT, below, we can see that prices just made an upside breakout at $115.37 and a $125 price target is being projected.
 
 
 
Bottom line strategy: ABT has made an upside breakout on the daily Point and Figure chart (above). Traders could use available weakness to go long. Risk a decline to $107. The $125 area is our first price objective. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Pharmaceuticals | Mad Money

More from Investing

Coupang Could Make a Bigger Trading Bounce

Bruce Kamich
Jul 1, 2022 1:56 PM EDT

Here's where nimble traders could probe the long side.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Bruce Kamich
Jul 1, 2022 1:13 PM EDT

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Shares of Xencor Could Be Bought on a 50% Correction

Bruce Kamich
Jul 1, 2022 11:59 AM EDT

Traders should remain patient.

Let's Size Up the Market's Prospects for the Second Half of 2022

Bret Jensen
Jul 1, 2022 11:30 AM EDT

The next six months can't be worse than the first six, can they?

In an Ugly First Half for Stocks, Value Was a Lot Less Ugly Than Growth

Jonathan Heller
Jul 1, 2022 11:00 AM EDT

A look at the Russell indexes shows that value stocks suffered in the first six months of 2022 but not nearly as much as growth issues.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login